
Clearview Cancer Institute is north Alabama's leading cancer treatment facility. For over 30 years Clearview Cancer Institute has provided leading-edge treatment and compassionate care to those diagnosed with cancer or blood disorders. Clearview offers every service and amenity needed in an outpatient setting and our dedication to research and involvement in Phase I-IV clinical trials gives our patients the opportunity to receive potentially life-saving treatment options.
Why Join Us? We are looking for talented and highly-motivated individuals who demonstrate a natural desire to support the meaningful work of community oncologists and the patients we serve.
Job purpose: Oversee the process of obtaining prior authorization for hematology and oncology treatments from insurance companies, ensuring timely access to necessary medications and therapies while adhering to clinical guidelines and payer requirements, by managing a team of prior authorization specialist and coordinating with healthcare providers and insurance companies to navigate complex authorization processes.
Duties include:
Team Leadership:
Clinical Review and Decision Making
Payer Management
Patient Advocacy
Data Analysis and Reporting
Compliance and Quality Assurance
Education/Experience
Working conditions:
This position works as part the business office of a busy outpatient oncology/hematology clinic overseeing the day-to-day operations of the prior authorization department.
Physical requirements:
This position requires that the employee be able to sit at a desk and work on a computer for up to eight hours a day
Direct reports
All Prior Authorization Specialist that are a part of the business office including float prior authorization specialist

Clearview Cancer Institute is north Alabama's leading cancer treatment facility. For over 30 years Clearview Cancer Institute has provided leading-edge treatment and compassionate care to those diagnosed with cancer or blood disorders. Clearview offers every service and amenity needed in an outpatient setting and our dedication to research and involvement in Phase I-IV clinical trials gives our patients the opportunity to receive potentially life-saving treatment options.